ResearchMoz added Latest Research Report titled " Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014 " to it's Large Report database.
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014
Summary
Global Markets Directs, Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014, provides an overview of the Acute Respiratory Distress Syndromes therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Respiratory Distress Syndrome and special features on late-stage and discontinued projects.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=195723
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Acute Respiratory Distress Syndrome Overview 8
Therapeutics Development 9
Pipeline Products for Acute Respiratory Distress Syndrome Overview 9
Pipeline Products for Acute Respiratory Distress Syndrome Comparative Analysis 10
Acute Respiratory Distress Syndrome Therapeutics under Development by Companies 11
Acute Respiratory Distress Syndrome Therapeutics under Investigation by Universities/Institutes 13
Acute Respiratory Distress Syndrome Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Acute Respiratory Distress Syndrome Products under Development by Companies 17
Acute Respiratory Distress Syndrome Products under Investigation by Universities/Institutes 18
Acute Respiratory Distress Syndrome Companies Involved in Therapeutics Development 19
Questcor Pharmaceuticals, Inc. 19
GlaxoSmithKline plc 20
Phylogica Limited 21
Altor BioScience Corporation 22
Therametrics holding AG 23
Northern Therapeutics, Inc. 24
Faron Pharmaceuticals Oy 25
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014
Summary
Global Markets Directs, Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014, provides an overview of the Acute Respiratory Distress Syndromes therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Respiratory Distress Syndrome and special features on late-stage and discontinued projects.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=195723
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Acute Respiratory Distress Syndrome Overview 8
Therapeutics Development 9
Pipeline Products for Acute Respiratory Distress Syndrome Overview 9
Pipeline Products for Acute Respiratory Distress Syndrome Comparative Analysis 10
Acute Respiratory Distress Syndrome Therapeutics under Development by Companies 11
Acute Respiratory Distress Syndrome Therapeutics under Investigation by Universities/Institutes 13
Acute Respiratory Distress Syndrome Pipeline Products Glance 14
Late Stage Products 14
Clinical Stage Products 15
Early Stage Products 16
Acute Respiratory Distress Syndrome Products under Development by Companies 17
Acute Respiratory Distress Syndrome Products under Investigation by Universities/Institutes 18
Acute Respiratory Distress Syndrome Companies Involved in Therapeutics Development 19
Questcor Pharmaceuticals, Inc. 19
GlaxoSmithKline plc 20
Phylogica Limited 21
Altor BioScience Corporation 22
Therametrics holding AG 23
Northern Therapeutics, Inc. 24
Faron Pharmaceuticals Oy 25
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
No comments:
Post a Comment